Speaker Profile

M.D., Ph.D., Co-founder, Chairman & CEO, Walking Fish Tx

Walking Fish Therapeutics launched on February 13, 2019. Prior to this he founded and served as a director, President & CEO of Five Prime Therapeutics, a public biotech company until January 2020. He held management positions and board seats at Chiron Corporation, now known as Novartis Vaccines and Diagnostics, Inc., COR Therapeutics, Inc., and Beckman Coulter, Inc. Dr. Williams was a professor of medicine at the University of California, San Francisco, and served as Director of the Universitys Cardiovascular Research Institution and Daiichi Research Center. Throughout his tenure at UCSF, he was an Investigator of the Howard Hughes Medical Institute. Dr. Williams also has served on the faculties of Harvard Medical School and Massachusetts General Hospital. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Dr. Williams received a B.S. from Rice University and an M.D. and Ph.D. from Duke University.

 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 26 9.00 A.M.-4.30 P.M.

Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2023 Luminary Award Ceremony
    Honoree: Bruce Levine, University of Pennsylvania
  • Advance and Optimize Cell Therapies in Oncology (PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - Lewis “Rusty” Williams, Walking Fish Therapeutics
    - Loïc VINCENT, Affini-T Therapeutics
    - Nick Haining, Arsenal
  • Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
    Chair: Carl June, UPenn
    - Lenny Dragone, Sonoma
    - James Chung, Kyverna
    - David Chang, Cabaletta
    - Cristina Musselli, Abata Therapeutics
  • Innovations in Cell Therapy Manufacturing (PANEL)
    Chair: Bruce Levine, University of Pennsylvania
    - Chris Holt, BMS
    - Heidi Hagen, Sonoma Bio
    - Rahul Singhvi, Resilience
    - Snehal Patel, Sana Biotechnology
  • Patentability of Immunotherapies - Latest Developments
    - Janet Xiao, Morrison & Foerster LLP
  • Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
    Chair: Jason Coloma, Maze Therapeutics
    - Peter DiLaura, Sonoma Bio
    - Nick Haining, Arsenal
    - Ulrik Nielsen, Sanofi
    - Lacey Padron, Parker Institute